Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil and Argentina cement certification ties

This article was originally published in Clinica

Executive Summary

Brazil's and Argentina's national technical standards bodies are about to sign an agreement confirming plans to collaborate in the development of certification services. The agreement will seek to "promote the joint delivery of certification services, without interfering in the two bodies' independence, in terms of issuing or revising certifications, or criteria-related policy-making", said the ABNT. While each body – Associação Brasileira de Normas Técnicas (ABNT) and Instituto Argentino de Normalização e Certificação (IRAM) – will operate "commercially" only in their own country, the agreement envisages joint training programmes and joint participation in initiatives to "develop and improve products and services". The signing is scheduled to take place in São Paulo, Brazil, on August 27, and will serve to confirm an initial collaboration agreement signed in May.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044096

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel